185 related articles for article (PubMed ID: 19820395)
1. Perillyl alcohol and methyl jasmonate sensitize cancer cells to cisplatin.
Yeruva L; Hall C; Elegbede JA; Carper SW
Anticancer Drugs; 2010 Jan; 21(1):1-9. PubMed ID: 19820395
[TBL] [Abstract][Full Text] [Related]
2. Methyl jasmonate decreases membrane fluidity and induces apoptosis through tumor necrosis factor receptor 1 in breast cancer cells.
Yeruva L; Elegbede JA; Carper SW
Anticancer Drugs; 2008 Sep; 19(8):766-76. PubMed ID: 18690087
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effects of autocrine motility factor and methyl jasmonate on human breast cancer cells.
Jeoung NH; Jo AL; Park HS
Biochem Biophys Res Commun; 2021 Jun; 558():22-28. PubMed ID: 33894674
[TBL] [Abstract][Full Text] [Related]
4. Enhanced killing of cervical cancer cells by combinations of methyl jasmonate with cisplatin, X or alpha radiation.
Milrot E; Jackman A; Flescher E; Gonen P; Kelson I; Keisari Y; Sherman L
Invest New Drugs; 2013 Apr; 31(2):333-44. PubMed ID: 22956285
[TBL] [Abstract][Full Text] [Related]
5. Methyl jasmonate sensitizes human bladder cancer cells to gambogic acid-induced apoptosis through down-regulation of EZH2 expression by miR-101.
Wang Y; Xiang W; Wang M; Huang T; Xiao X; Wang L; Tao D; Dong L; Zeng F; Jiang G
Br J Pharmacol; 2014 Feb; 171(3):618-35. PubMed ID: 24490857
[TBL] [Abstract][Full Text] [Related]
6. Methyl jasmonate down-regulates survivin expression and sensitizes colon carcinoma cells towards TRAIL-induced cytotoxicity.
Raviv Z; Zilberberg A; Cohen S; Reischer-Pelech D; Horrix C; Berger MR; Rosin-Arbesfeld R; Flescher E
Br J Pharmacol; 2011 Nov; 164(5):1433-44. PubMed ID: 21486277
[TBL] [Abstract][Full Text] [Related]
7. Perillyl alcohol and perillic acid induced cell cycle arrest and apoptosis in non small cell lung cancer cells.
Yeruva L; Pierre KJ; Elegbede A; Wang RC; Carper SW
Cancer Lett; 2007 Nov; 257(2):216-26. PubMed ID: 17888568
[TBL] [Abstract][Full Text] [Related]
8. Delayed cytotoxic effects of methyl jasmonate and cis-jasmone induced apoptosis in prostate cancer cells.
Yeruva L; Pierre KJ; Bathina M; Elegbede A; Carper SW
Cancer Invest; 2008 Nov; 26(9):890-9. PubMed ID: 18798057
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effect of TMZ-POH on human nasopharyngeal carcinoma depends on reactive oxygen species accumulation.
Xie L; Song X; Guo W; Wang X; Wei L; Li Y; Lv L; Wang W; Chen TC; Song X
Oncotarget; 2016 Jan; 7(2):1651-62. PubMed ID: 26625208
[TBL] [Abstract][Full Text] [Related]
10. Design and production of methyl jasmonate nanoemulsions using experimental design technique and evaluation of its anti-cancer efficacy.
Habibi K; Sepehri H; Delphi L; Mirjalili MH; Rafati H
Pharmazie; 2017 Nov; 72(11):652-662. PubMed ID: 29442039
[TBL] [Abstract][Full Text] [Related]
11. Methyl jasmonate: a plant stress hormone as an anti-cancer drug.
Cohen S; Flescher E
Phytochemistry; 2009 Sep; 70(13-14):1600-9. PubMed ID: 19660769
[TBL] [Abstract][Full Text] [Related]
12. Cooperative cytotoxicity of methyl jasmonate with anti-cancer drugs and 2-deoxy-D-glucose.
Heyfets A; Flescher E
Cancer Lett; 2007 Jun; 250(2):300-10. PubMed ID: 17125916
[TBL] [Abstract][Full Text] [Related]
13. PI3K/Akt pathway activation attenuates the cytotoxic effect of methyl jasmonate toward sarcoma cells.
Elia U; Flescher E
Neoplasia; 2008 Nov; 10(11):1303-13. PubMed ID: 18953440
[TBL] [Abstract][Full Text] [Related]
14. Association between reversal of multidrug resistance by methyl jasmonate and P-glycoprotein ATPase activity in hepatocellular carcinoma.
Wang CF; Wang YQ; Huang FZ; Nie WP; Liu XY; Jiang XZ
J Int Med Res; 2013 Aug; 41(4):964-74. PubMed ID: 23867448
[TBL] [Abstract][Full Text] [Related]
15. Combination of Ad-sTRAIL with the chemotherapeutic drug cisplatin synergistically enhances their pro-apoptotic ability in human breast cancer cells.
Liu X; Wang J; Wang H; Liu S; Liang Y; Lv Z; Zhou Q; Ding W
Oncol Rep; 2013 Oct; 30(4):1913-9. PubMed ID: 23912708
[TBL] [Abstract][Full Text] [Related]
16. Predominant enhancement of apoptosis induced by methyl jasmonate in bladder cancer cells: therapeutic effect of the Antp-conjugated Smac peptide.
Xiao XY; Jiang GS; Wang L; Lv L; Zeng FQ
Anticancer Drugs; 2011 Oct; 22(9):853-63. PubMed ID: 21642838
[TBL] [Abstract][Full Text] [Related]
17. Methyl jasmonate attenuated lipopolysaccharide-induced depressive-like behaviour in mice.
Adebesin A; Adeoluwa OA; Eduviere AT; Umukoro S
J Psychiatr Res; 2017 Nov; 94():29-35. PubMed ID: 28647678
[TBL] [Abstract][Full Text] [Related]
18. Methyl jasmonate induced apoptosis in human prostate carcinoma cells via 5-lipoxygenase dependent pathway.
Ezekwudo DE; Wang RC; Elegbede JA
J Exp Ther Oncol; 2007; 6(4):267-77. PubMed ID: 18038760
[TBL] [Abstract][Full Text] [Related]
19. Methyl jasmonate reduces the survival of cervical cancer cells and downregulates HPV E6 and E7, and survivin.
Milrot E; Jackman A; Kniazhanski T; Gonen P; Flescher E; Sherman L
Cancer Lett; 2012 Jun; 319(1):31-8. PubMed ID: 22198483
[TBL] [Abstract][Full Text] [Related]
20. Effect of methyl jasmonate and 3-bromopyruvate combination therapy on mice bearing the 4 T1 breast cancer cell line.
Yousefi S; Darvishi P; Yousefi Z; Pourfathollah AA
J Bioenerg Biomembr; 2020 Apr; 52(2):103-111. PubMed ID: 31960257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
